Anticancer drugs: A deeper understanding of VEGFR inhibitors

Comment

Charlotte Harrison. Nat Rev Drug Discov. 2012 Nov.

. 2012 Nov;11(11):831.

doi: 10.1038/nrd3873. Epub 2012 Oct 12.

No abstract available

Republished in

Angiogenesis: A deeper understanding of VEGFR inhibitors.
Harrison C. Harrison C. Nat Rev Cancer. 2012 Nov;12(11):735. doi: 10.1038/nrc3390. Nat Rev Cancer. 2012. PMID: 23090026 No abstract available.

Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors.
McTigue M, Murray BW, Chen JH, Deng YL, Solowiej J, Kania RS. McTigue M, et al. Proc Natl Acad Sci U S A. 2012 Nov 6;109(45):18281-9. doi: 10.1073/pnas.1207759109. Epub 2012 Sep 17. Proc Natl Acad Sci U S A. 2012. PMID: 22988103 Free PMC article.